Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
- PMID: 29455792
- PMCID: PMC5902823
- DOI: 10.1016/j.ihj.2016.12.021
Left ventricular structure and diastolic function by cardiac magnetic resonance imaging in hypertrophic cardiomyopathy
Abstract
Objective: Diastolic dysfunction is common in hypertrophic cardiomyopathy (HCM) and hypertensive heart disease (HHD), but its relationships with left ventricular (LV) parameters have not been well studied. Our objective was to assess the relationship of various measures of diastolic function, and maximum left ventricular wall thickness (MLVWT) and left ventricular mass index (LVMI) in HCM, HHD and normal controls using cardiac magnetic resonance imaging (CMR). We also assessed LV parameters and diastolic function in relation to late gadolinium enhancement (LGE) and right ventricular (RV) hypertrophy in HCM.
Methods: 41 patients with HCM, 21 patients with HHD and 20 controls were studied. Peak filling rate (PFR), time to peak filling (TPF), MLVWT and LVMI were measured using CMR. LGE and RV morphology were assessed in HCM patients.
Results: MLVWT correlated with TPF in HCM (r=0.38; p=0.02), HHD (r=0.58; p=0.01) and controls (r=0.54; p=0.01); correlation between MLVWT and TPF was weaker in HCM than HHD. LVMI did not correlate with diastolic function. In HCM, LGE extent correlated with MLVWT (τ=0.41; p=0.002) and with TPF (τ=0.29; p=0.02). The HCM patients with RV hypertrophy had higher MLVWT (p<0.001) and TPF (p=0.03) than patients without RV hypertrophy.
Conclusion: MLVWT correlates with diastolic function (TPF) in HCM, HHD and controls. LVMI did not show significant correlation with TPF. The diastolic dysfunction in HCM is not entirely explained by wall thickening. LGE and RV involvement are associated with worse LV diastolic function, suggesting that these may be markers of more severe underlying myocardial disarray and fibrosis that contribute to diastolic dysfunction.
Keywords: Diastolic function; Hypertension; Hypertrophic cardiomyopathy; Left ventricle; Magnetic resonance imaging.
Copyright © 2016. Published by Elsevier B.V.
Figures



Similar articles
-
Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.J Am Coll Cardiol. 2019 May 28;73(20):2493-2502. doi: 10.1016/j.jacc.2019.02.065. J Am Coll Cardiol. 2019. PMID: 31118142 Free PMC article.
-
Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric cardiovascular magnetic resonance discriminators when end-diastolic wall thickness ≥ 15 mm.Eur Radiol. 2017 Mar;27(3):1125-1135. doi: 10.1007/s00330-016-4468-2. Epub 2016 Jul 1. Eur Radiol. 2017. PMID: 27368925
-
Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.Eur Radiol. 2015 Apr;25(4):1190-200. doi: 10.1007/s00330-014-3390-8. Epub 2015 Jan 18. Eur Radiol. 2015. PMID: 25597022
-
Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.Cardiol J. 2016;23(3):250-63. doi: 10.5603/CJ.a2016.0019. Epub 2016 Apr 11. Cardiol J. 2016. PMID: 27064795 Review.
-
The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.J Cardiovasc Transl Res. 2009 Dec;2(4):415-25. doi: 10.1007/s12265-009-9136-3. Epub 2009 Nov 7. J Cardiovasc Transl Res. 2009. PMID: 20560000 Review.
Cited by
-
Cardiac magnetic resonance analysis of left atrium function in patients with pre-apical hypertrophic cardiomyopathy.Quant Imaging Med Surg. 2024 Jan 3;14(1):888-897. doi: 10.21037/qims-23-466. Epub 2024 Jan 2. Quant Imaging Med Surg. 2024. PMID: 38223022 Free PMC article.
-
Left Ventricular Diastolic Function Studied with Magnetic Resonance Imaging: A Systematic Review of Techniques and Relation to Established Measures of Diastolic Function.Diagnostics (Basel). 2021 Jul 16;11(7):1282. doi: 10.3390/diagnostics11071282. Diagnostics (Basel). 2021. PMID: 34359363 Free PMC article. Review.
-
The Impact of Mavacamten on the Pathophysiology of Hypertrophic Cardiomyopathy: A Narrative Review.Am J Cardiovasc Drugs. 2022 Sep;22(5):497-510. doi: 10.1007/s40256-022-00532-x. Epub 2022 Apr 18. Am J Cardiovasc Drugs. 2022. PMID: 35435607 Free PMC article. Review.
-
Subcellular microRNAs in diabetic cardiomyopathy.Ann Transl Med. 2020 Dec;8(23):1602. doi: 10.21037/atm-20-2205. Ann Transl Med. 2020. PMID: 33437801 Free PMC article. Review.
-
Reference data for left ventricular filling and atrial function in children using cardiovascular magnetic resonance.J Cardiovasc Magn Reson. 2023 Jun 12;25(1):30. doi: 10.1186/s12968-023-00936-x. J Cardiovasc Magn Reson. 2023. PMID: 37308942 Free PMC article.
References
-
- Gaasch W.H., Zile M.R. Left ventricular diastolic dysfunction and diastolic heart failure. Annu Rev Med. 2004;55:373–394. - PubMed
-
- Yancy C.W., Jessup M., Bozkurt B. ACCF/AHA guideline for the management of heart failure. J Am Coll Cardiol. 2013;62(16):147–239. - PubMed
-
- Motoyasu M., Kurita T., Onishi K. Correlation between late gadolinium enhancement and diastolic function in hypertrophic cardiomyopathy assessed by magnetic resonance imaging. Circ J. 2008;72:378–383. - PubMed
-
- Małek Ł.A., Chojnowska L., Kłopotowski M. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy. Kardiol Pol. 2009;67:1–6. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources